HomeALC • SWX
add
Alcon AG
Previous close
CHF 62.48
Day range
CHF 62.44 - CHF 63.56
Year range
CHF 61.70 - CHF 87.00
Market cap
31.18B CHF
Avg Volume
1.34M
P/E ratio
34.86
Dividend yield
0.45%
Primary exchange
SWX
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.60B | 4.01% |
Operating expense | 1.14B | 8.98% |
Net income | 176.00M | -21.08% |
Net profit margin | 6.78 | -24.08% |
Earnings per share | 0.76 | 2.70% |
EBITDA | 629.00M | 1.94% |
Effective tax rate | 11.56% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.41B | 2.62% |
Total assets | 31.39B | 5.62% |
Total liabilities | 9.26B | 5.47% |
Total equity | 22.13B | — |
Shares outstanding | 494.40M | — |
Price to book | 1.40 | — |
Return on assets | 2.32% | — |
Return on capital | 2.65% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 176.00M | -21.08% |
Cash from operations | 505.00M | -4.72% |
Cash from investing | -154.00M | -15.79% |
Cash from financing | -383.00M | -123.98% |
Net change in cash | -4.00M | -101.73% |
Free cash flow | 336.38M | -10.57% |
About
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Founded
1945
Headquarters
Website
Employees
25,000
